COMPLETE CITATION
Citation and identifiers
Jhanji M, et al.. “Dynamic regulation of the chromatin environment by ASH1L modulates human neuronal structure and function.” bioRxiv. 2024.12.02.625500 · doi:10.1101/2024.12.02.625500.
- PubMed ID
- 39677608 ↗
RESEARCH QUESTION
How do ASH1L variants alter chromatin, transcription, splicing, morphology, and function in human iPSC-derived neurons, and can neurite phenotypes be rescued in vitro?
The preprint studies ASH1L-variant human neurons and reports cultured-cell pharmacologic rescue of neurite phenotypes, which remains preclinical evidence rather than treatment guidance.
INTERPRETATION BOUNDARY
Read the finding and limit together.
What this study supports
Uses ASH1L-variant human iPSC-derived neurons to examine chromatin, transcription, splicing, morphology, and in-vitro pharmacologic rescue of neurite phenotypes.
What it cannot establish
Preprint and in-vitro evidence. Tazemetostat or vorinostat rescue in cultured neurons is not clinical treatment evidence.
OPEN THE STUDY